M. Dixon

Nivolumab + low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.

E. Van Cutsem, M. Overman, S. Lonardi, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer

I. Lugowska, S. Lonardi, J. Raimbourg, 2024, Frontiers in Pharmacology.